Free Trial

Aurora Cannabis (ACB) Competitors

Aurora Cannabis logo
$5.17 -0.25 (-4.61%)
Closing price 04:00 PM Eastern
Extended Trading
$5.15 -0.02 (-0.46%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ACB vs. CGC, CRON, OGI, SNDL, TLRY, VFF, COLL, NTLA, CVAC, and ELVN

Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF), Collegium Pharmaceutical (COLL), Intellia Therapeutics (NTLA), CureVac (CVAC), and Enliven Therapeutics (ELVN).

Aurora Cannabis vs. Its Competitors

Aurora Cannabis (NASDAQ:ACB) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership and earnings.

Aurora Cannabis has a net margin of -5.66% compared to Canopy Growth's net margin of -155.76%. Aurora Cannabis' return on equity of -1.49% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-5.66% -1.49% -1.06%
Canopy Growth -155.76%-89.93%-44.24%

Aurora Cannabis has higher revenue and earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora Cannabis$246.72M1.18$1.63M-$0.19-27.21
Canopy Growth$225.65M1.58-$429.86M-$3.03-0.49

Aurora Cannabis has a beta of 1.91, meaning that its share price is 91% more volatile than the S&P 500. Comparatively, Canopy Growth has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.00
Canopy Growth
2 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.33

47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Comparatively, 0.2% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Canopy Growth had 11 more articles in the media than Aurora Cannabis. MarketBeat recorded 12 mentions for Canopy Growth and 1 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.96 beat Canopy Growth's score of 0.83 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aurora Cannabis
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Canopy Growth
5 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Aurora Cannabis beats Canopy Growth on 12 of the 16 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACB vs. The Competition

MetricAurora CannabisMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$305.98M$11.00B$5.75B$9.77B
Dividend YieldN/A1.84%6.66%4.50%
P/E Ratio-27.2114.4862.2622.40
Price / Sales1.1831.30537.34111.77
Price / Cash8.8725.1325.7028.92
Price / Book0.693.4511.196.58
Net Income$1.63M$211.94M$3.28B$265.84M
7 Day Performance-2.45%-1.16%0.15%-0.07%
1 Month Performance15.40%13.38%8.34%5.83%
1 Year Performance-14.97%-8.99%54.21%17.88%

Aurora Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACB
Aurora Cannabis
0.2489 of 5 stars
$5.17
-4.6%
N/A-10.9%$305.98M$246.72M-27.211,130Gap Down
CGC
Canopy Growth
1.2132 of 5 stars
$1.80
-4.3%
N/A-65.5%$431.73M$225.65M0.003,150Short Interest ↓
Gap Down
CRON
Cronos Group
1.7943 of 5 stars
$2.60
flat
N/A+15.0%$995.90M$117.61M0.00450Analyst Upgrade
OGI
Organigram Global
1.5626 of 5 stars
$1.73
flat
N/A-6.5%$231.91M$117.47M0.00860News Coverage
Positive News
Gap Down
SNDL
SNDL
2.2865 of 5 stars
$2.68
-0.4%
$4.00
+49.3%
+36.0%$704.24M$671.81M0.002,516Gap Down
TLRY
Tilray Brands
3.0876 of 5 stars
$1.38
-6.1%
$1.94
+40.4%
-19.3%$1.52B$821.31M0.002,842Short Interest ↓
Gap Down
VFF
Village Farms International
0.7802 of 5 stars
$3.27
+3.8%
N/A+217.5%$368.35M$336.18M0.001,400Short Interest ↑
Gap Down
COLL
Collegium Pharmaceutical
2.8473 of 5 stars
$38.80
+1.2%
$42.33
+9.1%
+0.9%$1.22B$631.45M6.68210Positive News
NTLA
Intellia Therapeutics
4.7318 of 5 stars
$11.35
-2.2%
$29.05
+156.0%
-49.4%$1.22B$57.88M0.00600News Coverage
Positive News
Gap Up
CVAC
CureVac
4.4724 of 5 stars
$5.37
flat
$6.83
+27.3%
+71.0%$1.20B$579.18M5.59880Positive News
ELVN
Enliven Therapeutics
2.7799 of 5 stars
$20.27
-0.4%
$41.20
+103.3%
-7.4%$1.20BN/A0.0050News Coverage

Related Companies and Tools


This page (NASDAQ:ACB) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners